More recently, increased p110δ mRNA expression and dysregulated p110δ-mediated signaling was associated with schizophrenia (Law et al., 2012), suggesting p110δ-selective inhibitors as a novel treatment strategy for schizophrenia and other psychotic diseases (Rico, 2012). Here, PIK3CD is linked to schizophrenia.